The FDA’s warnings are specifically geared toward patients who take the 10-milligram dose of the medicine, known as tofacitinib, twice a day.
The regulatory agency also said it is limiting the use of the treatment for ulcerative colitis so that patients can only take it if they have severe side effects from other medicines...
buh-bye junkies...
Saudi_FDA
As the warnings clearly state
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: